Aspen Laser Launches New Ascent Laser Series
Aspen Laser Systems, LLC, an emerging global leader in the medical device industry, with a focus on photobiomodulation, announced the…
Author: Bjørn Dahl
DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced it…
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet
Alafair Biosciences, Inc., is revolutionizing soft tissue protection with innovative hydrogel medical devices, today announced that its flagship product, VersaWrap Hydrogel…
SKAN, the Wellcome Sanger Institute and University of Newcastle to study early stem cell mutations in rare blood disorder
SKAN Research Trust (SKAN), promoted by Indian entrepreneur Ashok Soota, today announced a joint research project with the UK-based Wellcome Sanger…
HealthXWire Awards R&R Medicinals Best New Product of 2024 for Topical Pain Relief
HealthXWire has honored R&R Medicinals, a provider of CBD products, with the Best New Product of 2024 for Topical Pain…
Groundbreaking Study by Dr. Agarwal’s Eye Hospital on post-crosslinking surgery patients Wins ‘Best Scientific Poster Award’ at ASCRS 2024 Annual Meeting
Dr Agarwal’s Eye Hospital recently announced that their accomplished research team have been honoured with the prestigious ‘Best Scientific Poster…
NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of enrollment of Part…
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Today, Ajinomoto Co., Inc. (“Ajinomoto Co.”) (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version…
M3 launches Doctors.net.uk: ‘Pathway’ to Support International Medical Graduates Relocating to the UK’
M3 (EU) has announced the international launch of ‘Doctors.net.uk: Pathway’, the latest addition to Doctors.net.uk, the UK’s leading online community…
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that Cell…